Bottom line
What is NYVTX's expense ratio?
NYVTX's expense ratio is 0.91%, or about $91 a year on every $10,000 invested. That is more expensive than 57% of large blend funds we track (median 0.83%). This share class also charges a front-end sales load of up to 4.75%, taken from your investment when you buy. Its expense ratio includes a 0.23% 12b-1 marketing fee.
Updated Nov 26, 2025
NYVTX fee table
| Net expense ratio | 0.91% |
|---|---|
| Gross expense ratio | 0.91% |
| Management fee | 0.54% |
| 12b-1 (distribution) fee | 0.23% |
| Other expenses | 0.14% |
| Max front-end sales load | 4.75% |
| Max deferred sales charge | 0.5% |
| Redemption fee | 0% |
Source: Fund prospectus fee table, filed Nov 26, 2025
What NYVTX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| NYVTX | $563 | $751 | $955 | $1,541 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.91% expense ratio costs roughly $50,800 in lost growth, versus about $46,700 for the median large blend fund (0.83%).